Table 3 Scoring of GI and GU disorders for WP and PO 3DCRT techniques.
| Incidence and development of acute GI/GU toxicity from pretreatment symptoms | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Acute GI toxicity | Acute GU toxicity | ||||||||
| WP | PO | WP | PO | ||||||
|
Pretreatment Symptoms | Acute toxicity | n | % | n | % | n | % | n | % |
| 0 → 0 | 33 | 28.45% | 40 | 49.38% | 43 | 37.07% | 36 | 44.44% | |
| 0 → 1 | 14 | 12.07% | 17 | 20.99% | 18 | 15.52% | 12 | 14.81% | |
| 0 → 2 | 58 | 50.00% | 20 | 24.69% | 25 | 21.55% | 17 | 20.99% | |
| 0 → 3 | 1 | 0.86% | 1 | 0.86% | |||||
| 1 → 0 | 1 | 1.23% | 13 | 11.21% | 7 | 8.64% | |||
| 1 → 1 | 2 | 2.47% | 6 | 5.17% | 3 | 3.70% | |||
| 1 → 2 | 5 | 4.31% | 1 | 1.23% | 4 | 3.45% | 3 | 3.70% | |
| 1 → 3 | 2 | 1.72% | |||||||
| 2 → 0 | 1 | 0.86% | 1 | 0.86% | 1 | 1.23% | |||
| 2 → 1 | 1 | 1.23% | |||||||
| 2 → 2 | 1 | 0.86% | 1 | 0.86% | |||||
| 2 → 3 | 2 | 1.72% | 1 | 1.23% | |||||
| 3 → 0 | 1 | 0.86% | |||||||
| 3 → 1 | |||||||||
| 3 → 2 | 1 | 0.72% | |||||||
| 3 → 3 | 1 | 0.86% | |||||||
| Development of late GI/GU toxicity from acute GI/GU toxicity | |||||||||
| GI toxicity | GU toxicity | ||||||||
| WP | PO | WP | PO | ||||||
| Acute toxicity | Late toxicity | n | % | n | % | n | % | n | % |
| 0 → 0 | 29 | 25.00% | 34 | 41.98% | 41 | 35.34% | 31 | 38.27% | |
| 0 → 1 | 5 | 4.31% | 5 | 6.17% | 13 | 11.21% | 8 | 9.88% | |
| 0 → 2 | 2 | 2.47% | 1 | 0.86% | 3 | 3.70% | |||
| 0 → 3 | 1 | 0.86% | 3 | 2.59% | 2 | 2.47% | |||
| 1 → 0 | 10 | 8.62% | 11 | 13.58% | 17 | 14.66% | 9 | 11.11% | |
| 1 → 1 | 4 | 3.45% | 7 | 8.64% | 4 | 3.45% | 2 | 2.47% | |
| 1 → 2 | 1 | 0.86% | 2 | 2.47% | |||||
| 1 → 3 | 1 | 1.23% | 2 | 1.72% | 3 | 3.70% | |||
| 2 → 0 | 47 | 40.52% | 9 | 11.11% | 18 | 15.52% | 10 | 12.35% | |
| 2 → 1 | 9 | 7.76% | 6 | 7.41% | 8 | 6.90% | 8 | 9.88% | |
| 2 → 2 | 5 | 4.31% | 5 | 6.17% | 3 | 2.59% | 2 | 2.47% | |
| 2 → 3 | 2 | 1.72% | 1 | 1.23% | 1 | 0.86% | |||
| 2 → 4 | 1 | 0.86% | |||||||
| 3 → 0 | 2 | 1.72% | |||||||
| 3 → 1 | 1 | 0.86% | 2 | 1.72% | |||||
| 3 → 2 | 1 | 0.86% | |||||||
| 3 → 3 | 1 | 0.86% | 1 | 1.23% | |||||
| Summary of last late GI/GU toxicities dynamics | |||||||||
| WP | PO | ||||||||
| Last late GI toxicity | n | % | n | % | |||||
| Patients without toxicity | 29 | 25.00% | 34 | 41.98% | |||||
| Decrease of toxicity (G1,2,3→G0) | 59 | 50.86% | 20 | 24.69% | |||||
| Patients with moderate toxicity-G1 | |||||||||
| Development G0 → G1 | 5 | 4.31% | 5 | 6.17% | |||||
| Unchanged grade of toxicity G1 | 4 | 3.45% | 7 | 8.64% | |||||
| Decrease of toxicity from G2, 3→ G1 | 10 | 8.62% | 6 | 7.41% | |||||
| Patients with high level toxicity G2, 3, 4 | 9 | 7.76% | 9 | 11.11% | |||||
| WP | PO | ||||||||
| Last late GU toxicity | n | % | n | % | |||||
| Patients without toxicity | 41 | 35.34% | 31 | 38.27% | |||||
| Decrease of toxicity (G1,2,3 → G0) | 35 | 30.17% | 19 | 23.46% | |||||
| Patients with moderate toxicity-G1 | |||||||||
| Development G0 → G1 | 13 | 11.21% | 8 | 9.88% | |||||
| Unchanged grade of toxicity G1 | 4 | 3.45% | 2 | 2.47% | |||||
| Decrease of toxicity from G2, 3→G1 | 10 | 8.62% | 8 | 9.88% | |||||
| Patients with high level toxicity G2, 3, 4 | 13 | 11.21% | 13 | 16.05% | |||||